Sveriges mest populära poddar
Conversations in Drug Development
Hälsa och motionMedicin

The Drug Development Landscape: Trends and Predictions for 2024

26 min•22 januari 2024

We are kickstarting 2024 with a Conversation in Drug Development with CEO and Founder of Boyds, Professor Alan Boyd. In this podcast episode, our host Harriet Edwards, and Professor Alan Boyd discuss trends from 2023  in the drug development space and its potential evolution in 2024. Join us as we explore the financial downturn affecting early-stage investment, the rise of cell and gene therapy approvals, and the use of artificial intelligence in various areas of drug discovery and development.

Fler avsnitt av Conversations in Drug Development

Visa alla avsnitt av Conversations in Drug Development
Live Biotherapeutics: Navigating the Next Frontier in Drug Development
•32 min
UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025
•26 min
How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?
•30 min
Navigating the FDA Landscape: More Changes, and What's Next?
•27 min
At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development
•40 min
Navigating the New FDA Landscape: Opportunities and Challenges Ahead
•36 min
From Lab to Launch – Avoiding the Pitfalls of Drug Development
•28 min
Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025
•33 min
How to Effectively De-Risk your IND Process
•53 min
Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators
•24 min

Conversations in Drug Development med Boyds finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.